Insmed Incorporated (United States) is listed on the Nasdaq and has a market capitalization of $25.77 billion, with shareholders equity totaling $726.21 million.
The company employs approximately 521 people and operates in the Health Care sector, within the Biotechnology industry.
Over the past 12 months, Insmed Incorporated reported $1.52 billion in revenue, generating net income of $-769.17 million.
Key financial metrics include a P/E ratio of -33.50, a price-to-book (P/B) ratio of 35.49, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker INSM.